(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
The purpose of Renal Cancer: Methods and Protocols is to introduce the surgeon, clinician, investigator, and research scientist to the basic methods employed in the diagnosis and treatment of renal cancer. Treatment of localized renal cancer is surgical. Treatment of metastasis with resection, radiotherapy, chemotherapy, and immunotherapy has had limited results. Therefore, new avenues of treatment are necessary. In planning this work, I have attempted to incorporate coverage by specialists from a variety of disciplines, each applying their individual expertise in renal cancer therapy. Though many of the participating authors are urologists, there are also valuable contributions from medical oncologists, laboratory inv- tigators, and pathologists. One of the inherent problems in publishing a book that describes molecular techniques, especially those techniques that are rapidly evolving, is that some of these may become obsolete after a few years. However, many of the procedures detailed here are standard approaches that have already wi- stood the test of time. Reverse transcriptase PCR, or RT-PCR, a technique that produces m- tiple copies of selected sequences of DNA, has a sensitivity of a millionfold amplication of a single cell, and thus constitutes a very precise technique for measuring the presence of tumor cells. By combining this technique with genomic hybridization, cadherin,ss and metalloproteinase expression we may then reveal other important factors in the detection, staging, aggressiveness, and treatment of this disease.
Contents:
Part I. Introduction. Renal Cell Carcinoma: Clinical Features and Management, Paul Russo. Pathology of Kidney Tumors, David J. Grignon. Part II. In Vitro Experimental Techniques. Telomerase Assay in Renal Cancer, William W. Zhang and Laurence H. Klotz. Comparative Genomic Hybridization, Joseph C. Presti, Jr. Analyzing the FHIT Gene by RT-PCR, Western Blotting, and Immunohistochemistry, Raffaele Baffa, Coleen M. Calviello, Teresa Druck, and Leonard G. Gomella. Detection of Apoptosis in Renal Cell Carcinoma, Kenneth J. Pienta and Jeffrey F. Williams. Fluorescence In Situ Hybridization (FISH) to Metaphase and Interphase Chromosomes, Jill A. Macoska. Polymerase Chain Reaction Detection of DNA Sequence Deletions, Jill A. Macoska. Matrix Metalloproteinases and Their Inhibitors, Alexander Kugler, Paul Thelen, and Rolf-Hermann Ringert. Purification of Growth Factor mRNA in Renal Tissues: bFGF-2, FGF-2, TGFa, and EGFR, Jack H. Mydlo. Laser-Capture Microdissection, Greg L. Griewe, Robert Dean, Wei Zhang, Isabella A. Sesterhenn, Shiv Srivastava, and Judd W. Moul. Expression of c-met and WT-1, Leslie Kushner, Pui Yan Chiu, Peter Pinto, and Gary Hal Weiss. Molecular Analysis of the von Hippel-Lindau Disease Gene, Allen Chernoff, Viera Kasparcova, W. Marston Linehan, and Catherine A. Stolle. Experimental Models and Methods in Antibody Targeting of Renal Cell Carcinoma, Robert L. Vessella, D. Scott Wilbur, Kent Buhler, and Paul H. Lange. Part III. In Vivo Experimental Techniques. Orthotopic Model of Renal Cell Carcinoma, David M. Nanus and Dov Engelstein. Murine Animal Model, Nobuyasu Nishisaka, Philo Morse, Richard F. Jones, Ching Y. Wang, and Gabriel P. Haas. Angiogenisis Assays, Jack H. Mydlo. Antiangiogenic Approaches to Renal Cell Carcinoma: Assays for Inhibitors and Clinical Trials, Steven C. Campbell, Frank K. Reiher, and Norman D. Smith, Jr. Part IV. Clinical Trials and Experiments. Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma, Belur Patel and Arie Belldegrun. Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination, Wilbur B. Browne, William G. Hawkins, and Jonathan J. Lewis. Monoclonal Antibodies: Generation and Clinical Use, Egbert Oosterwijk. Treatment Strategies in Metastatic Renal Cell Carcinoma: Cytokines, Vaccines, and Gene Therapy, Peter F. Mulders. Assessment of T-Cell Immune Dysfunction in Patients with Renal Cell Carcinoma, Robert G. Uzzo, Vladimir Kolenko, Andrew C. Novick, and James H. Finke. Transforming Growth Factor-b1 as a Novel Marker of Response to Therapy for Renal Cell Carcinoma, Howard L. Adler. Static and Flow Cytometry, Ralph Madeb, Dov Pode, and Ofer Nativ. Index.
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: November, 2010
Pages: 416
Weight: 612g
Availability: Available
Subcategories: Oncology
From the same series
